Premium
Improving access to acute stroke therapies: a controlled trial of organised pre‐hospital and emergency care
Author(s) -
Quain Debbie A,
Parsons Mark W,
Loudfoot Allan R,
Spratt Neil J,
Evans Malcolm K,
Russell Michelle L,
Royan Angela T,
Moore Andrea G,
Miteff Ferdinand,
Hullick Carolyn J,
Attia John,
McElduff Patrick,
Levi Christopher R
Publication year - 2008
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2008.tb02114.x
Subject(s) - medicine , triage , emergency department , stroke (engine) , thrombolysis , emergency medicine , referral , acute stroke , acute care , tissue plasminogen activator , health care , myocardial infarction , mechanical engineering , engineering , economics , economic growth , family medicine , psychiatry
Objective: To assess the effectiveness of the PAST (Pre‐hospital Acute Stroke Triage) protocol in reducing pre‐hospital and emergency department (ED) delays to patients receiving organised acute stroke care, thereby increasing access to thrombolytic therapy. Design: Prospective cohort study using historical controls. Setting: Hunter Region of New South Wales, September 2005 to March 2006 (pre‐intervention) and September 2006 to March 2007 (post‐intervention). Participants: Consecutive patients presenting with acute stroke to a regional, tertiary referral hospital. Intervention: PAST protocol, comprising a pre‐hospital stroke assessment tool for ambulance officers, an ambulance protocol for hospital bypass for potentially thrombolysis‐eligible patients, and pre‐hospital notification of the acute stroke team. Main outcome measures: Proportion of patients who received intravenous tissue plasminogen activator (tPA), process of care time points (symptom onset to ED arrival, ED arrival to tPA treatment, and ED transit time), and clinical outcomes of patients treated with tPA. Results: The proportion of ischaemic stroke patients treated with tPA increased from 4.7% (pre‐intervention) to 21.4% (post‐intervention) ( P < 0.001). Time point outcomes also improved, with a reduction in median times from symptom onset to ED arrival from 150 to 90.5 min ( P = 0.004) and from ED arrival to stroke unit admission from 361 to 232.5 minutes ( P < 0.001). Of those treated with tPA, 43% had minimal or no disability at 3 months. Conclusions: Organised pre‐hospital and ED acute stroke care increases patient access to tPA treatment, which is proven to reduce stroke‐related disability.